Skip to content

Fine mapping

Catalog entries using this tag (links open the entry card on its page):

Entries

OmiGA

eQTL Colocalization Fine mapping Multi-omics Tool
PUBMED_LINK
41680153
DESCRIPTION
Toolkit for molecular QTL (molQTL) mapping using linear mixed models that handle complex relatedness, aimed at high-throughput omics phenotypes with strong performance for discovery, fine mapping, and trait–molQTL colocalization versus common linear-mapper pipelines.
URL
https://omiga.bio/ ,https://doi.org/10.1038/s41467-026-68978-0
KEYWORDS
molQTL, xQTL, LMM, relatedness, colocalization, fine mapping
TITLE
OmiGA for ultra-efficient molecular quantitative trait loci mapping.
Main citation
Teng J, Zhang W, Gong W, Chen J, ...&, Zhang Z. (2026) OmiGA for ultra-efficient molecular quantitative trait loci mapping. Nat Commun, 17 (1) . doi:10.1038/s41467-026-68978-0. PMID 41680153
ABSTRACT
Molecular quantitative trait loci (molQTL) mapping is one of the most popular approaches to systematically characterize functional impacts of genomic variants, leading to advanced understanding of the regulatory mechanisms underpinning complex traits and diseases. However, when applied to high-throughput molecular phenotypes, the existing molQTL mapping tools often implement simple linear models, overlooking complex inter-individual relatedness, leading to false positives and insufficient statistical power. Here, we introduce OmiGA, an ultra-efficient omics genetic analysis toolkit, for molQTL mapping based on linear mixed model in populations with complex relatedness. Both computational simulations and real data analyses demonstrate that OmiGA outperforms the existing popular tools regarding molQTL discovery power, fine mapping of causal variants, colocalization of molQTL and trait associations, and computational efficiency. In summary, we recommend OmiGA for molQTL mapping in populations with complex relatedness, for example, those in the Farm animal Genotype-Tissue Expression project and family-based molQTL studies in humans.
DOI
10.1038/s41467-026-68978-0

TGVIS

TWAS Gene prioritization Fine mapping Tool Summary statistics
PUBMED_LINK
40603866
FULL NAME
Tissue-Gene pairs, direct causal Variants, and Infinitesimal effects selector
DESCRIPTION
Multivariate TWAS approach that prioritizes causal gene–tissue pairs and candidate causal variants from GWAS summary data while explicitly controlling for genome-wide infinitesimal (polygenic) effects that can otherwise inflate false gene discoveries.
URL
https://github.com/harryyiheyang/TGVIS ,https://doi.org/10.1038/s41467-025-61423-8
KEYWORDS
multivariate TWAS, infinitesimal model, causal gene-tissue, eQTL, sQTL
TITLE
Uncovering causal gene-tissue pairs and variants through a multivariate TWAS controlling for infinitesimal effects.
Main citation
Yang Y, Lorincz-Comi N, Zhu X. (2025) Uncovering causal gene-tissue pairs and variants through a multivariate TWAS controlling for infinitesimal effects. Nat Commun, 16 (1) 6098. doi:10.1038/s41467-025-61423-8. PMID 40603866
ABSTRACT
Transcriptome-wide association studies (TWAS) are commonly used to prioritize causal genes underlying associations found in genome-wide association studies (GWAS) and have been extended to identify causal genes through multivariate TWAS methods. However, recent studies have shown that widespread infinitesimal effects due to polygenicity can impair the performance of these methods. In this report, we introduce a multivariate TWAS method named tissue-gene pairs, direct causal variants, and infinitesimal effects selector (TGVIS) to identify tissue-specific causal genes and direct causal variants while accounting for infinitesimal effects. In simulations, TGVIS maintains an accurate prioritization of causal gene-tissue pairs and variants and demonstrates comparable or superior power to existing approaches, regardless of the presence of infinitesimal effects. In the real data analysis of GWAS summary data of 45 cardiometabolic traits and expression/splicing quantitative trait loci from 31 tissues, TGVIS is able to improve causal gene prioritization and identifies novel genes that were missed by conventional TWAS.
DOI
10.1038/s41467-025-61423-8